Kathy D. Miller, MD

News

PATINA Trial Shifts Paradigm in HER2+/ER+ Breast Cancer Treatment, Prolonging Survival With Targeted Combination Therapy

Author:: Kathy D. Miller, MD

Publish date: March 4, 2025

PATINA enrolled patients who were receiving their first chemotherapy and HER2-tar...

Opinion

Considering the true costs of clinical trials

Author:: Kathy D. Miller, MD

Publish date: August 9, 2023

There are many subtle and some egregious ways that participating in clinical trials can result in increased costs.

Article

Advances in Breast Cancer From AACR 2023

Author:: Kathy D. Miller, MD

Publish date: May 4, 2023

Therapies combining PARP plus PD-L1 inhibition, PARP inhibition plus chemotherapy, and whole tumor cell therapeutic vaccines are among breast cance...

Article

Key Takeaways in Early Breast Cancer From AACR 2023

Author:: Kathy D. Miller, MD

Publish date: May 4, 2023

A novel agent used to visualize positive margins in lumpectomy, the effect of race on skin toxicity in radiotherapy, and DCIS recurrence are key hi...

News

ASCO 2021: Breast cancer sessions not to miss

Author:: Kathy D. Miller, MD

Publish date: June 4, 2021

Dr. Kathy Miller gives her picks for the best breast cancer sessions at the American Society of Clinical Oncology...